Defining the Success of AF Ablation: What Should it Be, What is Important?

Description

This session different perspectives as to what is or should be considered an important outcome for AF ablation will be discussed.

Learning Objectives

Describe the endpoints which may be considered in determining the success of AF ablation.
Outline perspectives from different stakeholders as to what is or should be considered an important outcome for AF ablation.
Compare the various strengths and limitations of various endpoints.

Session Chair(s)

Hugh Calkins, MD
Janet Han, MD

Presentation

Determining the Success of AF Ablation: Time to Recurrence vs AF Burden
Presenter(s): Jonathan P. Piccini, MD, MHS

Reported Success Rates of AF Ablation Trials: Impact of the Monitoring Strategy Used During fFollow-up
Presenter(s): Martin Aguilar, MD, PhD

Important Outcomes of AF Ablation to the Electrophysiologist: Health Care Utilization and QOL
Presenter(s): Louise Segan, MBBS, MPH

Patient Perspective
Presenter(s): Daniel Green

Time Course and Significance of Recurrent Arrhythmias After AF Ablation: Implication for Guidelines and Clinical Trials
Presenter(s): Mohan N. Viswanathan, MD

Disclosures

Jonathan Piccini:

Boston Scientific (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Bayer Healthcare Pharmaceuticals (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Abbott (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Philips (Research (Contracted Grants for PIs and Named Investigators only) - Research)
iRhythm Technologies (Research (Contracted Grants for PIs and Named Investigators only) - Research)
Biotronik (Honoraria/Speaking/Consulting Fee - Consulting)
LivaNova (Honoraria/Speaking/Consulting Fee - Events adjudication)
Philips (Honoraria/Speaking/Consulting Fee - Consulting)
Medtronic (Honoraria/Speaking/Consulting Fee - Consulting)
ElectroPhysiology Frontiers (Honoraria/Speaking/Consulting Fee - Consulting)
Milestone Pharmaceuticals (Honoraria/Speaking/Consulting Fee - Consulting)
Sanofi (Honoraria/Speaking/Consulting Fee - Consulting)
Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
UpToDate, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
Kardium (Honoraria/Speaking/Consulting Fee - Data Safety and Monitoring Board)
ABVF (Honoraria/Speaking/Consulting Fee - Consulting)

Martin Aguilar:

Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)

Louise Segan:

Nothing Relevant to Disclose

Daniel Green:

Nothing Relevant to Disclose

Mohan Viswanathan:

Nothing Relevant to Disclose

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Education Framework

Supraventricular Tachyarrhythmias
-- AFib and Flutter - Catheter Ablation
-- 159. Know the follow-up and management of recurrent atrial arrhythmia following ablation.

Summary


Availability:	No future session


Cost:	FREE


Credit Offered:	No Credit Offered

Recommended

Abstract Catalog 2025: ePosters

FREE